Griffin Asset Management Inc. Purchases 7,170 Shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Griffin Asset Management Inc. grew its position in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) by 31.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,135 shares of the company’s stock after acquiring an additional 7,170 shares during the quarter. Griffin Asset Management Inc. owned 0.94% of ALPS Medical Breakthroughs ETF worth $1,125,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. DAVENPORT & Co LLC increased its position in shares of ALPS Medical Breakthroughs ETF by 12.1% during the 1st quarter. DAVENPORT & Co LLC now owns 771,189 shares of the company’s stock valued at $27,461,000 after purchasing an additional 83,403 shares during the last quarter. Central Valley Advisors LLC bought a new position in shares of ALPS Medical Breakthroughs ETF during the 1st quarter valued at approximately $200,000. Virtu Financial LLC bought a new position in shares of ALPS Medical Breakthroughs ETF during the 4th quarter valued at approximately $518,000. Financial Advocates Investment Management increased its position in shares of ALPS Medical Breakthroughs ETF by 5.3% during the 2nd quarter. Financial Advocates Investment Management now owns 7,670 shares of the company’s stock valued at $258,000 after purchasing an additional 385 shares during the last quarter. Finally, Ridgewood Investments LLC bought a new position in shares of ALPS Medical Breakthroughs ETF during the 2nd quarter valued at approximately $675,000.

ALPS Medical Breakthroughs ETF Stock Up 0.2 %

Shares of ALPS Medical Breakthroughs ETF stock opened at $38.64 on Wednesday. The stock’s fifty day moving average is $36.92 and its two-hundred day moving average is $35.16. ALPS Medical Breakthroughs ETF has a 52 week low of $23.21 and a 52 week high of $39.37.

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.